UK markets open in 3 hours 34 minutes
NIKKEI 225
38,090.87 +129.07 (+0.34%) HANG SENG
16,477.29 +225.45 (+1.39%) CRUDE OIL
82.81 +0.12 (+0.15%) GOLD FUTURES
2,387.20 -1.20 (-0.05%) DOW
37,753.31 -45.66 (-0.12%) Bitcoin GBP
49,868.91 -1,485.07 (-2.89%)
Journey Medical Corporation (DERM)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 76.94M |
| Enterprise value | 64.23M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.93 |
| Price/book (mrq) | 3.72 |
| Enterprise value/revenue | 0.81 |
| Enterprise value/EBITDA | 33.44 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.81 |
| 52-week change 3 | 139.45% |
| S&P500 52-week change 3 | 21.61% |
| 52-week high 3 | 8.1100 |
| 52-week low 3 | 1.0200 |
| 50-day moving average 3 | 3.8938 |
| 200-day moving average 3 | 3.6890 |
Share statistics
| Avg vol (3-month) 3 | 178.63k |
| Avg vol (10-day) 3 | 244.05k |
| Shares outstanding 5 | 13.93M |
| Implied shares outstanding 6 | 19.93M |
| Float 8 | 8.25M |
| % held by insiders 1 | 29.91% |
| % held by institutions 1 | 9.72% |
| Shares short (28 Mar 2024) 4 | 148.09k |
| Short ratio (28 Mar 2024) 4 | 0.86 |
| Short % of float (28 Mar 2024) 4 | 1.43% |
| Short % of shares outstanding (28 Mar 2024) 4 | 0.74% |
| Shares short (prior month 29 Feb 2024) 4 | 64.39k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -4.87% |
| Operating margin (ttm) | -13.79% |
Management effectiveness
| Return on assets (ttm) | 0.74% |
| Return on equity (ttm) | -20.64% |
Income statement
| Revenue (ttm) | 79.18M |
| Revenue per share (ttm) | 4.34 |
| Quarterly revenue growth (yoy) | -4.40% |
| Gross profit (ttm) | N/A |
| EBITDA | 4.84M |
| Net income avi to common (ttm) | -3.85M |
| Diluted EPS (ttm) | -0.2100 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 27.44M |
| Total cash per share (mrq) | 1.38 |
| Total debt (mrq) | 17.73M |
| Total debt/equity (mrq) | 87.12% |
| Current ratio (mrq) | 1.35 |
| Book value per share (mrq) | 1.05 |
Cash flow statement
| Operating cash flow (ttm) | 5.24M |
| Levered free cash flow (ttm) | -4.7M |
© 2024 Yahoo. All rights reserved.